<DOC>
	<DOCNO>NCT00690482</DOCNO>
	<brief_summary>The purpose study study efficacy safety AZD1981 patient Chronic Obstructive Pulmonary Disease</brief_summary>
	<brief_title>Study Assess Efficacy Safety AZD1981 Patients With Moderate Severe Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>FEV1 30 80 % predict normal value postbronchodilator ( GOLD stag 2 3 ) Clinical diagnosis COPD Other clinically relevant disease disorder Exacerbation COPD within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>COPD</keyword>
</DOC>